No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
Identifieur interne : 002176 ( PubMed/Corpus ); précédent : 002175; suivant : 002177No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
Auteurs : Janet W. De Beukelaar ; Georges M. Verjans ; Yvette Van Norden ; Johannes C. Milikan ; Jaco Kraan ; Herbert Hooijkaas ; Kees Sintnicolaas ; Jan W. Gratama ; Peter A. Sillevis SmittSource :
- Cancer immunology, immunotherapy : CII [ 0340-7004 ] ; 2007.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies (blood), CD4-Positive T-Lymphocytes (immunology), CD8-Positive T-Lymphocytes (immunology), Child, Child, Preschool, ELAV Proteins (blood), ELAV Proteins (immunology), Female, Flow Cytometry, Humans, Leukocytes, Mononuclear (immunology), Male, Middle Aged, Paraneoplastic Syndromes (blood), Paraneoplastic Syndromes (immunology), T-Lymphocyte Subsets (immunology).
- MESH :
- chemical , blood : Antibodies, ELAV Proteins.
- blood : Paraneoplastic Syndromes.
- immunology : CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, ELAV Proteins, Leukocytes, Mononuclear, Paraneoplastic Syndromes, T-Lymphocyte Subsets.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Flow Cytometry, Humans, Male, Middle Aged.
Abstract
In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies (Hu-PNS), Hu antigens expressed by the tumour hypothetically trigger an immune response that also reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized CD8(+ )T cell-mediated immune pathogenesis of these syndromes, we searched for circulating HuD-specific CD8(+) T cells in a large cohort of Hu-PNS patients and controls.
DOI: 10.1007/s00262-007-0295-2
PubMed: 17597332
Links to Exploration step
pubmed:17597332Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.</title><author><name sortKey="De Beukelaar, Janet W" sort="De Beukelaar, Janet W" uniqKey="De Beukelaar J" first="Janet W" last="De Beukelaar">Janet W. De Beukelaar</name><affiliation><nlm:affiliation>Department of Medical Oncology, Room E-2-80B, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Verjans, Georges M" sort="Verjans, Georges M" uniqKey="Verjans G" first="Georges M" last="Verjans">Georges M. Verjans</name></author><author><name sortKey="Van Norden, Yvette" sort="Van Norden, Yvette" uniqKey="Van Norden Y" first="Yvette" last="Van Norden">Yvette Van Norden</name></author><author><name sortKey="Milikan, Johannes C" sort="Milikan, Johannes C" uniqKey="Milikan J" first="Johannes C" last="Milikan">Johannes C. Milikan</name></author><author><name sortKey="Kraan, Jaco" sort="Kraan, Jaco" uniqKey="Kraan J" first="Jaco" last="Kraan">Jaco Kraan</name></author><author><name sortKey="Hooijkaas, Herbert" sort="Hooijkaas, Herbert" uniqKey="Hooijkaas H" first="Herbert" last="Hooijkaas">Herbert Hooijkaas</name></author><author><name sortKey="Sintnicolaas, Kees" sort="Sintnicolaas, Kees" uniqKey="Sintnicolaas K" first="Kees" last="Sintnicolaas">Kees Sintnicolaas</name></author><author><name sortKey="Gratama, Jan W" sort="Gratama, Jan W" uniqKey="Gratama J" first="Jan W" last="Gratama">Jan W. Gratama</name></author><author><name sortKey="Sillevis Smitt, Peter A" sort="Sillevis Smitt, Peter A" uniqKey="Sillevis Smitt P" first="Peter A" last="Sillevis Smitt">Peter A. Sillevis Smitt</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17597332</idno><idno type="pmid">17597332</idno><idno type="doi">10.1007/s00262-007-0295-2</idno><idno type="wicri:Area/PubMed/Corpus">002176</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002176</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.</title><author><name sortKey="De Beukelaar, Janet W" sort="De Beukelaar, Janet W" uniqKey="De Beukelaar J" first="Janet W" last="De Beukelaar">Janet W. De Beukelaar</name><affiliation><nlm:affiliation>Department of Medical Oncology, Room E-2-80B, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Verjans, Georges M" sort="Verjans, Georges M" uniqKey="Verjans G" first="Georges M" last="Verjans">Georges M. Verjans</name></author><author><name sortKey="Van Norden, Yvette" sort="Van Norden, Yvette" uniqKey="Van Norden Y" first="Yvette" last="Van Norden">Yvette Van Norden</name></author><author><name sortKey="Milikan, Johannes C" sort="Milikan, Johannes C" uniqKey="Milikan J" first="Johannes C" last="Milikan">Johannes C. Milikan</name></author><author><name sortKey="Kraan, Jaco" sort="Kraan, Jaco" uniqKey="Kraan J" first="Jaco" last="Kraan">Jaco Kraan</name></author><author><name sortKey="Hooijkaas, Herbert" sort="Hooijkaas, Herbert" uniqKey="Hooijkaas H" first="Herbert" last="Hooijkaas">Herbert Hooijkaas</name></author><author><name sortKey="Sintnicolaas, Kees" sort="Sintnicolaas, Kees" uniqKey="Sintnicolaas K" first="Kees" last="Sintnicolaas">Kees Sintnicolaas</name></author><author><name sortKey="Gratama, Jan W" sort="Gratama, Jan W" uniqKey="Gratama J" first="Jan W" last="Gratama">Jan W. Gratama</name></author><author><name sortKey="Sillevis Smitt, Peter A" sort="Sillevis Smitt, Peter A" uniqKey="Sillevis Smitt P" first="Peter A" last="Sillevis Smitt">Peter A. Sillevis Smitt</name></author></analytic><series><title level="j">Cancer immunology, immunotherapy : CII</title><idno type="ISSN">0340-7004</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antibodies (blood)</term><term>CD4-Positive T-Lymphocytes (immunology)</term><term>CD8-Positive T-Lymphocytes (immunology)</term><term>Child</term><term>Child, Preschool</term><term>ELAV Proteins (blood)</term><term>ELAV Proteins (immunology)</term><term>Female</term><term>Flow Cytometry</term><term>Humans</term><term>Leukocytes, Mononuclear (immunology)</term><term>Male</term><term>Middle Aged</term><term>Paraneoplastic Syndromes (blood)</term><term>Paraneoplastic Syndromes (immunology)</term><term>T-Lymphocyte Subsets (immunology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies</term><term>ELAV Proteins</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Paraneoplastic Syndromes</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term><term>CD8-Positive T-Lymphocytes</term><term>ELAV Proteins</term><term>Leukocytes, Mononuclear</term><term>Paraneoplastic Syndromes</term><term>T-Lymphocyte Subsets</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Flow Cytometry</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies (Hu-PNS), Hu antigens expressed by the tumour hypothetically trigger an immune response that also reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized CD8(+ )T cell-mediated immune pathogenesis of these syndromes, we searched for circulating HuD-specific CD8(+) T cells in a large cohort of Hu-PNS patients and controls.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17597332</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0340-7004</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><Issue>9</Issue><PubDate><Year>2007</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cancer immunology, immunotherapy : CII</Title><ISOAbbreviation>Cancer Immunol. Immunother.</ISOAbbreviation></Journal><ArticleTitle>No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.</ArticleTitle><Pagination><MedlinePgn>1501-6</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies (Hu-PNS), Hu antigens expressed by the tumour hypothetically trigger an immune response that also reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized CD8(+ )T cell-mediated immune pathogenesis of these syndromes, we searched for circulating HuD-specific CD8(+) T cells in a large cohort of Hu-PNS patients and controls.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Blood was tested from 43 Hu-PNS patients, 31 Hu antibody negative SCLC patients without PNS and 54 healthy controls. Peripheral blood mononuclear cells (PBMC) were stimulated with HuD protein-spanning peptide pools (15-mers) and individual HuD-derived peptides (9-mers) and analysed by cytokine flow cytometry and interferon-gamma ELISPOT-assays. Additionally, HuD-based Class I HLA multimers were used to visualize HuD-specific CD8(+) T cells.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No HuD-specific CD8(+ )T cells could be detected in the blood of Hu-PNS patients or controls.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results do not support a role for HuD-specific CD8(+) T cells in Hu-PNS. Further studies should focus on the detection of circulating HuD-specific CD4(+ )T cells and examine the antigen specificity of T cells in affected tissues.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Beukelaar</LastName><ForeName>Janet W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Room E-2-80B, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verjans</LastName><ForeName>Georges M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>van Norden</LastName><ForeName>Yvette</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Milikan</LastName><ForeName>Johannes C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Kraan</LastName><ForeName>Jaco</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hooijkaas</LastName><ForeName>Herbert</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sintnicolaas</LastName><ForeName>Kees</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Gratama</LastName><ForeName>Jan W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Sillevis Smitt</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Cancer Immunol Immunother</MedlineTA><NlmUniqueID>8605732</NlmUniqueID><ISSNLinking>0340-7004</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051959">ELAV Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051959" MajorTopicYN="N">ELAV Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010257" MajorTopicYN="N">Paraneoplastic Syndromes</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>6</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>6</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17597332</ArticleId><ArticleId IdType="doi">10.1007/s00262-007-0295-2</ArticleId><ArticleId IdType="pmc">PMC1914259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Immunol. 2000 Jun;30(6):1676-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10898504</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2001 Sep 1;98(5):1358-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11520783</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11517302</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2002 Jan;122(1-2):100-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11777548</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2002 May;103(5):509-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11935268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2002 Jun;249(6):745-53</Citation><ArticleIdList><ArticleId IdType="pubmed">12111309</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2002 Sep 15;201(1-2):9-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12163187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2003 Feb;9(2):606-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12576425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2003 Mar;4(3):201</Citation><ArticleIdList><ArticleId IdType="pubmed">12605223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2003 Sep;142(1-2):93-100</Citation><ArticleIdList><ArticleId IdType="pubmed">14512168</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Oct 16;349(16):1543-54</Citation><ArticleIdList><ArticleId IdType="pubmed">14561798</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Feb;78(4):1775-81</Citation><ArticleIdList><ArticleId IdType="pubmed">14747542</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15258215</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1994 Jan;44(1):140-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8290049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1995 Jul;38(1):102-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7541976</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1995 Oct;45(10):1873-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7477985</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1996 May 14;93(10):4529-36</Citation><ArticleIdList><ArticleId IdType="pubmed">8643438</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 1997 Aug 22;74(4):378-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9291425</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1997 Dec;27(12):3259-68</Citation><ArticleIdList><ArticleId IdType="pubmed">9464814</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1998 Oct;51(4):1146-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9781545</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 1998 Nov;4(11):2819-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9829748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1999 Feb;45(2):162-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9989617</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurooncol. 2005 Feb;71(3):231-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15735910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):562-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16543544</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Biosci. 2006;11:1932-44</Citation><ArticleIdList><ArticleId IdType="pubmed">16368569</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2006 Mar;11(3):292-305</Citation><ArticleIdList><ArticleId IdType="pubmed">16549814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002176 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002176 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:17597332
|texte= No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17597332" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |